Status:
UNKNOWN
Effect of Mango on Gut Microbiota and Metabolic Health
Lead Sponsor:
Laval University
Conditions:
Gut Microbiota
Metabolic Syndrome
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Mango is rich in bioactive compounds such as dietary polyphenols and carotenoids, which may explain its beneficial effect on health. Polyphenols accumulate in the gut where they can positively modulat...
Eligibility Criteria
Inclusion
- Healthy men and premenopausal women
- At least one of the following : BMI between 25 and 40 kg/m2 or Waist circumference ≥ 80 cm for women and ≥ 94 cm for men
- At least one of the following : TG ≥ 1.35 mmol/L or fasting insulinemia ≥ 42 pmol/L
- Caucasian origin
Exclusion
- Nicotine use
- Metabolic disorders or use of medication that may affect parameters measured in the study
- Use of dietary supplements or natural health product that may affect parameters measured in the study
- Use of antibiotics in the last 3 months
- Surgery in the last 3 months or planned during the study timeline
- Alcohol consumption \>2 drinks/day
- Weight change \>5% in the last 3 months
- Mango aversion, allergy or intolerance
- Dietary restrictions (vegetarian, gluten avoidance...)
- Berries consumption \>1 serving/day
- Pregnancy, breastfeeding or pregnancy planned within 3-6 months
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03825276
Start Date
January 15 2019
End Date
December 1 2022
Last Update
July 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laval University
Québec, Canada, G1V 0A6